Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
41.94
-0.11 (-0.26%)
Mar 6, 2026, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Employees
As of December 31, 2025, Xenon Pharmaceuticals had 370 total employees, including 358 full-time and 12 part-time employees. The number of employees increased by 43 or 13.15% compared to the previous year.
Employees
370
Change (1Y)
43
Growth (1Y)
13.15%
Revenue / Employee
$20,270
Profits / Employee
-$934,892
Market Cap
3.49B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ACADIA Pharmaceuticals | 798 |
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| Denali Therapeutics | 503 |
| Tarsus Pharmaceuticals | 370 |
| Alumis | 223 |
| Centessa Pharmaceuticals | 114 |
XENE News
- 9 days ago - Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study - GlobeNewsWire
- 7 weeks ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout - Seeking Alpha
- 3 months ago - Xenon Pharmaceuticals Inc. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation Transcript - Seeking Alpha